.png
)
69th DCC Recommends Mandatory Public Disclosure of Suspended and Cancelled Drug Licenses Vaayath Regulatory Desk | Drugs Consultative Committee, 69th Meeting | Held on 24.06.2026 The Drugs Consultative Committee (DCC), at its 69th meeting held on 24.06.2026, took up an…
Vaayath Consulting Services Regulatory Update · CDSCO / Gazette Notification Drugs (Eighth Amendment) Rules, 2026: CLAA Licensing Framework Now Explicitly Covers Cell & Stem Cell Products, Gene Therapeutics and Xenografts G.S.R. 530(E) brings advanced therapy products formally within the same…
CDSCO · Drugs Rules Amendment · GSR 506(E) Schedule H2 Expanded: Vaccines, Antimicrobials, Narcotic Drugs & Anticancer Medicines Now Under Stricter Prescription Controls 📅 Gazette Date: 22 June 2026 ⚖️ Effective: 1 July 2027 (Antimicrobials: 1 July 2028) 🏛 Ministry…
CDSCO Circular: Supply of IVF Media & ART Consumables Restricted to Registered Centres Only | Vaayath Consulting Regulatory Update · Medical Devices CDSCO Directs Stakeholders: IVF Media, Reagents & ART Consumables Must Be Supplied Only to Registered Centres 📅 23…
CDSCO Circular New Drugs Division NDCT Rules 2019 Formulation Intermediates Modified Release 24 June 2026 ⚠ Regulatory Action — Immediate Attention Required All manufacturers and importers of formulation intermediates including SR/ER/PR/DR pellets, directly compressible granules, taste-masked granules, and modified release…